Related Experiment Videos
[Using botulinum toxin type A in the gastrointestinal tract]
Martin Storr1, Hans-Dieter Allescher
1II. Medizinische Klinik und Poliklinik der Technischen Universität München, Klinikum rechts der Isar.
Medizinische Klinik (Munich, Germany : 1983)
|August 10, 2002
Summary
Botulinum toxin (BTX) injections offer a safe, reversible therapy for gastrointestinal spastic disorders like achalasia and anal fissures. While effective, its temporary nature is beneficial for fissures but a drawback for achalasia treatment.
Area of Science:
- Gastroenterology
- Neurology
- Pharmacology
Context:
- Botulinum toxin (BTX) selectively inhibits neurotransmitter release from cholinergic neurons.
- Local intrasphincteric BTX injection is a potential therapy for gastrointestinal spastic disorders.
Purpose:
- To evaluate the clinical benefit and safety of BTX injections for various gastrointestinal spastic conditions.
- To compare the efficacy and side effect profile of BTX with other treatment modalities.
Summary:
- BTX injections are clinically beneficial for achalasia and chronic anal fissures.
- Potential applications in sphincter of Oddi dysfunction and cervical achalasia require further investigation.
- BTX treatment is reversible and temporary, with a duration of several months.
Impact:
- BTX offers a novel, low-side-effect interventional option for specific gastrointestinal spastic disorders.
- The temporary effect is advantageous for anal fissure healing but a limitation for achalasia.
- Judicious application of BTX can benefit patient treatment outcomes.